Back
Venus Concept 10K Form
Sell
36
VERO
Venus Concept
Last Price:
0.28
Seasonality Move:
-11.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-03-30 | 10K | VERO/Venus Concept Annual |
| 2019-11-14 | 10Q | VERO/Venus Concept Quarterly |
| 2019-08-14 | 10Q | VERO/Venus Concept Quarterly |
| 2019-07-09 | 10K | VERO/Venus Concept Annual |
| 2019-05-15 | 10Q | VERO/Venus Concept Quarterly |
| 2019-04-29 | 10K | VERO/Venus Concept Annual |
Receive VERO News And Ratings
See the #1 stock for the next 7 days that we like better than VERO
VERO Financial Statistics
Sales & Book Value
| Annual Sales: | $76.35M |
|---|---|
| Cash Flow: | $-3.05M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.39 |
| Price / Book: | 0.23 |
Profitability
| EPS (TTM): | -8.02000 |
|---|---|
| Net Income (TTM): | $-50.15M |
| Gross Margin: | $52.17M |
| Return on Equity: | 0% |
| Return on Assets: | -58.35% |
Venus Concept Earnings Forecast
Key Venus Concept Financial Ratios
- The Gross Profit Margin over the past 9 years for VERO is 68.32%.
- The Selling, General & Administrative Expenses for VERO have been equal to 94.66% of Gross Profit Margin.
- The Research & Development expenses have been 10.74% of Revenue.
- The Interest Expense is -18.50% of Operating Income.
- The Net Earning history of VERO is -48.79% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 6 years.
Venus Concept Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | VERO |
| CUSIP: | 92332W |
| Website: | venusconcept.com |
Debt
| Debt-to-Equity Ratio: | 3.42 |
|---|---|
| Current Ratio: | 1.86 |
| Quick Ratio: | 0.96 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VERO Technical Analysis vs Fundamental Analysis
Sell
36
Venus Concept (VERO)
is a Sell
Is Venus Concept a Buy or a Sell?
-
Venus Concept stock is rated a Sell
The current Venus Concept [VERO] share price is $0.30. The Score for VERO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.